Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer

2019 ◽  
Vol 40 (3) ◽  
pp. 278-286 ◽  
Author(s):  
Alondra Escudero-Castellanos ◽  
Blanca Ocampo-García ◽  
Guillermina Ferro-Flores ◽  
Clara Santos-Cuevas ◽  
Enrique Morales-Ávila ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Preclinical Evaluation ◽  
Psma Inhibitor

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

2015 ◽  
Vol 56 (6) ◽  
pp. 914-920 ◽  
Author(s):  
M. Bene ova ◽  
M. Schafer ◽  
U. Bauder-Wust ◽  
A. Afshar-Oromieh ◽  
C. Kratochwil ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Preclinical Evaluation ◽  
Psma Inhibitor

scholarly journals Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

2012 ◽  
Vol 7 (1) ◽  
pp. 154 ◽  
Author(s):  
Colin Brooks ◽  
Tommy Sheu ◽  
Kathleen Bridges ◽  
Kathy Mason ◽  
Deborah Kuban ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Human Prostate ◽  
Human Prostate Cancer ◽  
Preclinical Evaluation

scholarly journals Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging

2019 ◽  
Vol 60 (9) ◽  
pp. 1284-1292 ◽  
Author(s):  
Teli Liu ◽  
Chen Liu ◽  
Xiaoxia Xu ◽  
Fei Liu ◽  
Xiaoyi Guo ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Study ◽  
Pet Imaging ◽  
Preclinical Evaluation ◽  
Pilot Clinical Study

Abstract LB-264: Preclinical evaluation of DNA-PK as a therapeutic target in prostate cancer

2017 ◽  
Author(s):  
Emanuela Dylgjeri ◽  
Jonathan F. Goodwin ◽  
Christopher M. McNair ◽  
Ayesha A. Shafi ◽  
Vishal Kothari ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Therapeutic Target ◽  
Preclinical Evaluation

Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer

2020 ◽  
Vol 45 (4) ◽  
pp. 288-291
Author(s):  
Ahu Özkan ◽  
Burcu Uçar ◽  
Hülya Seymen ◽  
Yasemin Yildiz Yarar ◽  
Fikri Okan Falay ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Inhibitor Therapy ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Critical Organ ◽  
Psma Inhibitor

Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer

2020 ◽  
Vol 17 (6) ◽  
pp. 1954-1962 ◽  
Author(s):  
James M. Kelly ◽  
Shashikanth Ponnala ◽  
Alejandro Amor-Coarasa ◽  
Nicholas A. Zia ◽  
Anastasia Nikolopoulou ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Preclinical Evaluation ◽  
High Affinity ◽  
Psma Ligand

scholarly journals Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Katharina Lückerath ◽  
Liu Wei ◽  
Wolfgang P. Fendler ◽  
Susan Evans-Axelsson ◽  
Andreea D. Stuparu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Receptor Blockade ◽  
Preclinical Evaluation ◽  
Psma Expression

Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable “click” oxime bond tethers and preclinical evaluation against prostate cancer

2020 ◽  
pp. 113018
Author(s):  
Eirinaios I. Vrettos ◽  
Theodoros Karampelas ◽  
Nisar Sayyad ◽  
Anastasia Kougioumtzi ◽  
Nelofer Syed ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Preclinical Evaluation
Sign in / Sign up

Export Citation Format

Share Document